19. April 2018
The Complete List and Analysis of the 10 Best Pharmaceutical Companies in 2018. 7 criteria have been considered including revenue, growth, R&D investments, and others. The global pharmaceutical market was estimated at USD 1.11 trillion in 2017 and projected to reach USD 1.43 trillion by 2020. In 2017, North America, Asia Pacific and Western Europe pharmaceutical market approximately accounted for 37%, 22% and 20% global market share respectively. In 2017, top-10 global pharmaceutical...
10. July 2017
Presentation by Dr. Dieter Lubda, Director, R&D Operations of Actives and Formulation, Merck KGaA, Germany @ BIT's 7th Annual International Symposium of Drug Delivery Systems July 12-14, 2017
05. July 2017
n this poster, Merck evaluate a pharmaceutical grade polyvinyl alcohol (PVA) as the matrix polymer for HME application…
26. June 2017
Mesoporous silicas (SLC) have demonstrated considerable potential to improve bioavailability of poorly soluble drugs by facilitating rapid dissolution and generating supersaturation. The addition of certain polymers can further enhance the dissolution of these formulations by preventing drug precipitation.
14. July 2016
Darmstadt, Germany, July 12, 2016 — Merck, a leading science and technology company, has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand Merck’s excipients portfolio. Under the agreement, Merck will be the exclusive, global distributor of the Expansorb® line of biocompatible and biodegradable polymers. More
06. March 2016
24th May 2016, 9:00 – 16:00 Conservatoire des Arts et Métiers, 292 rue Saint-martin, 75141 Paris Complete Programme Registration
08. February 2016
Thursday, March 10, 2016 QbD (Quality by Design) is of growing importance to the pharmaceutical industry – both for novel drugs and generics. Driven by health authorities worldwide, pharmaceutical manufacturers are under increasing pressure to implement QbD principles and thereby increase control over product quality. This also impacts excipient supply. More Information & Registration
27. October 2015
BILLERICA, Mass., Oct. 26, 2015 /PRNewswire/ -- EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, today introduced Parteck® SRP 80, a new functional excipient for oral sustained-release formulations. Parteck® SRP 80 is a polyvinyl alcohol (PVA) based excipient specifically designed for modified-release applications, for optimization of pharmacokinetics and pharmacodynamics as well as the bioavailability of actives. The new excipient is fully synthetic, ensuring...
20. October 2015
By Dan Stanton+, 20-Oct-2015 EMD Millipore will offer drugmakers two-years of unlimited access to its suite of raw materials dossiers for 20,000€ as part of its enhanced portfolio offering. More